SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-045030
Filing Date
2023-12-15
Accepted
2023-12-15 15:45:22
Documents
15
Period of Report
2023-12-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 86303
2 ex3-1.htm EX-3.1 10475
3 ex4-1.htm EX-4.1 210190
4 ex4-2.htm EX-4.2 9232
  Complete submission text file 0001493152-23-045030.txt   539484

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ogen-20231214.xsd EX-101.SCH 3018
6 XBRL LABEL FILE ogen-20231214_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ogen-20231214_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3478
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 231490100
SIC: 2834 Pharmaceutical Preparations